Merck Says Vaccine Buyers Must Arbitrate Antitrust Suit

By Kevin Stawicki · September 18, 2020, 6:00 PM EDT

Merck Sharp & Dohme Corp. is doubling down on its bid to arbitrate claims in a proposed class action alleging it violated federal antitrust law by selling overpriced vaccines after the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE ROTAVIRUS VACCINES ANTITRUST LITIGATION

Case Number

2:18-cv-01734

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

April 25, 2018